Literature DB >> 23065268

Genetic and environmental factors in human osteoporosis.

Halil Özbaş1, Serap Tutgun Onrat, Kazım Özdamar.   

Abstract

Osteoporosis is a common disorder, with prolongation of the average life span it has become a major public health problem. On the formation of osteoporosis genetic factors and environmental influences could play a role then it is considered as multi-factorial. Because a variety of functions to affect susceptibility to the formation of osteoporosis VDR-F, VDR-B, COL1A1, ESR1X, ESR1P and CTR are thought to be candidate genes. In this study, the aim is to investigate the relationship between these genes polymorphism and bone mineral density (BMD) values of lumbar vertebra and femoral neck in 188 Turkish people. Lumbar spine and femoral neck BMD of the individuals included in the study were measured by the dual X-ray absorptiometry method. The genotyped polymorphisms by simultaneous amplification of five regions of the genome, containing six SNPs of interest and detecting the amplified product, using the kit MetaBone Clinical Arrays(®). Statistical analyses indicated that; VDR-B gene polymorphisms major (P = 0.013), VDR-F polymorphisms have minor (P = 0.082) effect on femur BMD. None of the other genes has any significant effect on spinal BMD. Patient age, body mass index and diet has significant effect on femoral and spinal BMD. Osteoporosis is a multi-factorial disease and many genetic and non-genetic risk factors contribute to the development of osteoporosis. Early detection of a genetic predisposition to osteoporosis should allow delay and/or limit unfavorable changes in the bone tissue.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065268     DOI: 10.1007/s11033-012-2038-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  28 in total

1.  Estrogen status and heredity are major determinants of premenopausal bone mass.

Authors:  R Armamento-Villareal; D T Villareal; L V Avioli; R Civitelli
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  History of arthritis and bone rarefaction evidence from paleopathology onwards.

Authors:  W J MacLennan
Journal:  Scott Med J       Date:  1999-02       Impact factor: 0.729

3.  Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus.

Authors:  F G Hustmyer; M Peacock; S Hui; C C Johnston; J Christian
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

4.  Association of CTR and COLIA1 alleles with BMD values in peri- and postmenopausal women.

Authors:  V Braga; M Mottes; S Mirandola; V Lisi; G Malerba; L Sartori; G Bianchi; D Gatti; M Rossini; D Bianchini; S Adami
Journal:  Calcif Tissue Int       Date:  2000-11       Impact factor: 4.333

5.  COL1A1, ESR1, VDR and TGFB1 polymorphisms and haplotypes in relation to BMD in Spanish postmenopausal women.

Authors:  M Bustamante; X Nogués; A Enjuanes; R Elosua; N García-Giralt; L Pérez-Edo; E Cáceres; R Carreras; L Mellibovsky; S Balcells; A Díez-Pérez; D Grinberg
Journal:  Osteoporos Int       Date:  2006-10-05       Impact factor: 4.507

6.  Relationship among VDR (BsmI and FokI), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men.

Authors:  V Braga; A Sangalli; G Malerba; M Mottes; S Mirandola; D Gatti; M Rossini; M Zamboni; S Adami
Journal:  Calcif Tissue Int       Date:  2002-05-27       Impact factor: 4.333

7.  Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women.

Authors:  C Vandevyver; J Vanhoof; K Declerck; P Stinissen; C Vandervorst; L Michiels; J J Cassiman; S Boonen; J Raus; P Geusens
Journal:  J Bone Miner Res       Date:  1999-09       Impact factor: 6.741

8.  Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study.

Authors:  H Kröger; J Huopio; R Honkanen; M Tuppurainen; E Puntila; E Alhava; S Saarikoski
Journal:  J Bone Miner Res       Date:  1995-02       Impact factor: 6.741

9.  Relationship of estrogen receptor genotypes to bone mineral density and to rates of bone loss in men.

Authors:  Sundeep Khosla; B Lawrence Riggs; Elizabeth J Atkinson; Ann L Oberg; Carmelo Mavilia; Francesca Del Monte; L Joseph Melton; Maria Luisa Brandi
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

10.  Vitamin D receptor alleles, bone mineral density and turnover in postmenopausal osteoporotic and healthy women.

Authors:  Belgin Süsleyici Duman; Refik Tanakol; Nevin Erensoy; Melek Oztürk; Selma Yilmazer
Journal:  Med Princ Pract       Date:  2004 Sep-Oct       Impact factor: 1.927

View more
  11 in total

1.  Evaluation of common variants in CNR2 gene for bone mineral density and osteoporosis susceptibility in postmenopausal women of Han Chinese.

Authors:  C Zhang; J Ma; G Chen; D Fu; L Li; M Li
Journal:  Osteoporos Int       Date:  2015-06-09       Impact factor: 4.507

2.  A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from southern Italy.

Authors:  Valeria Conti; Giusy Russomanno; Graziamaria Corbi; Giuseppe Toro; Vittorio Simeon; Walter Filippelli; Nicola Ferrara; Michela Grimaldi; Valeria D'Argenio; Nicola Maffulli; Amelia Filippelli
Journal:  Int J Mol Sci       Date:  2015-03-10       Impact factor: 5.923

Review 3.  The transforming growth factor-β1 (TGF-β1) gene polymorphisms (TGF-β1 T869C and TGF-β1 T29C) and susceptibility to postmenopausal osteoporosis: a meta-analysis.

Authors:  Jiajia Sun; Chi Zhang; Lei Xu; Mingyuan Yang; Huilin Yang
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

4.  Analysis of association of MEF2C, SOST and JAG1 genes with bone mineral density in Mexican-Mestizo postmenopausal women.

Authors:  Rafael Velázquez-Cruz; Rogelio F Jiménez-Ortega; Alma Y Parra-Torres; Manuel Castillejos-López; Nelly Patiño; Manuel Quiterio; Teresa Villarreal-Molina; Jorge Salmerón
Journal:  BMC Musculoskelet Disord       Date:  2014-11-28       Impact factor: 2.362

5.  Association of vitamin D receptor ApaI gene polymorphism with osteoporosis susceptibility in postmenopausal Han Chinese women in Xinjiang.

Authors:  Defeng Meng; Xiao Ding; Jiaojiao Lan; Fangliang Peng; Weiguo Zhu; Zeyu Cheng; Haoruo Jia; Hao Xu; Chenhui Shi; Lijuan Pang; Wei Shan Wang
Journal:  Biomed Rep       Date:  2018-10-03

6.  The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database.

Authors:  Gyu Lee Kim; Yu Hyeon Yi; Hye Rim Hwang; Jinmi Kim; Youngmin Park; Yun Jin Kim; Jeong Gyu Lee; Young Jin Tak; Seung Hun Lee; Sang Yeoup Lee; Youn Hye Cho; Eun Ju Park; Youngin Lee
Journal:  J Clin Med       Date:  2021-05-10       Impact factor: 4.241

7.  Association between Vitamin D Receptor Gene BsmI Polymorphism and Bone Mineral Density in A Population of 146 Iranian Women.

Authors:  Farkhondeh Pouresmaeili; Javad Jamshidi; Eznollah Azargashb; Shahdokht Samangouee
Journal:  Cell J       Date:  2013-05-05       Impact factor: 2.479

8.  4q22.1 contributes to bone mineral density and osteoporosis susceptibility in postmenopausal women of Chinese Han population.

Authors:  Haojie Yang; Bo Zhang; Jialin Zhu; Dan Liu; Fanglin Guan; Xijing He
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

9.  Endochondral ossification pathway genes and postmenopausal osteoporosis: Association and specific allele related serum bone sialoprotein levels in Han Chinese.

Authors:  Yunzhi Zhang; Haiyan Liu; Chen Zhang; Tianxiao Zhang; Bo Zhang; Lu Li; Gang Chen; Dongke Fu; KunZheng Wang
Journal:  Sci Rep       Date:  2015-11-16       Impact factor: 4.379

10.  Evaluation of common variants in the CNR2 gene and its interaction with abdominal obesity for osteoporosis susceptibility in Chinese post-menopausal females.

Authors:  W Zheng; C Liu; M Lei; Y Han; X Zhou; C Li; S Sun; X Ma
Journal:  Bone Joint Res       Date:  2019-12-03       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.